| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |